Cart
sales@molnova.com
CDK9 inhibitor HH1
CAS No. 204188-41-0
CDK9 inhibitor HH1( —— )
Catalog No. M13175 CAS No. 204188-41-0
CDK9 inhibitor HH1 is a novel potent, highly selective CDK9 inhibitor.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 1 mL x 10 mM in DMSO | 28 | In Stock |
|
| 10MG | 29 | In Stock |
|
| 25MG | 48 | In Stock |
|
| 50MG | 69 | In Stock |
|
| 100MG | Get Quote | In Stock |
|
| 200MG | Get Quote | In Stock |
|
| 500MG | Get Quote | In Stock |
|
| 1G | Get Quote | In Stock |
|
Biological Information
-
Product NameCDK9 inhibitor HH1
-
NoteResearch use only, not for human use.
-
Brief DescriptionCDK9 inhibitor HH1 is a novel potent, highly selective CDK9 inhibitor.
-
DescriptionCDK9 inhibitor HH1 is a novel potent, highly selective CDK9 inhibitor.
-
In Vitro——
-
In Vivo——
-
Synonyms——
-
PathwayAngiogenesis
-
TargetCDK
-
RecptorCDK
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number204188-41-0
-
Formula Weight261.343
-
Molecular FormulaC13H15N3OS
-
Purity>98% (HPLC)
-
Solubility——
-
SMILESCC(C)NC1=NC(=C(S1)C(=O)C2=CC=CC=C2)N
-
Chemical Name(4-amino-2-(isopropylamino)thiazol-5-yl)(phenyl)methanone
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1. Zhang H, et al. Cell. 2018 Nov 15;175(5):1244-1258.e26.
molnova catalog
related products
-
LEE011
LEE011 is an orally available, and highly specific CDK4/6 inhibitor. Phase 3.
-
THZ-1
A potent, selective, covalent CDK7 inhibitor with IC50 of 3.2 nM; also weakly inhibits CDK12 with IC50 of 250 nM; displays broad-based activity a subset of cancer cell lines with IC50s of <200 nM.
-
CDK inhibitor E9
CDK inhibitor E9 is a novel CDK inhibitor that can overcomes ABC-mediated resistance of THZ1, functions as a potent, non-covalent inhibitor of CDK9 and a covalent inhibitor of CDK12.
